Cite
Autoantibodies against the melanoma differentiation–associated protein 5 in patients with dermatomyositis target the helicase domains.
MLA
Gompel, Eveline Van, et al. “Autoantibodies against the Melanoma Differentiation–associated Protein 5 in Patients with Dermatomyositis Target the Helicase Domains.” Rheumatology, vol. 63, no. 5, May 2024, pp. 1466–73. EBSCOhost, https://doi.org/10.1093/rheumatology/kead400.
APA
Gompel, E. V., Demirdal, D., Fernandes-Cerqueira, C., Horuluoglu, B., Galindo-Feria, A., Wigren, E., Gräslund, S., Langhe, E. D., Benveniste, O., Notarnicola, A., Chemin, K., & Lundberg, I. E. (2024). Autoantibodies against the melanoma differentiation–associated protein 5 in patients with dermatomyositis target the helicase domains. Rheumatology, 63(5), 1466–1473. https://doi.org/10.1093/rheumatology/kead400
Chicago
Gompel, Eveline Van, Deniz Demirdal, Catia Fernandes-Cerqueira, Begum Horuluoglu, Angeles Galindo-Feria, Edvard Wigren, Susanne Gräslund, et al. 2024. “Autoantibodies against the Melanoma Differentiation–associated Protein 5 in Patients with Dermatomyositis Target the Helicase Domains.” Rheumatology 63 (5): 1466–73. doi:10.1093/rheumatology/kead400.